Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1801 - 1900
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1801 | 26602374 |
US |
||
Feeling abnormal, Asthenia, Bone pain, Gait disturbance, Emotional disorder, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 1802 | 26590583 |
US |
||
Influenza like illness, Myalgia, Gait disturbance, |
||||
TRASTUZUMAB, |
||||
| 1803 | 26590588 |
US |
84 | |
Gait disturbance, Hypersensitivity, Influenza like illness, Somnolence, Pain, Pain, Swelling, |
||||
TRASTUZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, AMLODIPINE, HYDROCHLOROTHIAZIDE, |
||||
| 1804 | 26590615 |
CO |
62 | 2 |
Gait disturbance, Neoplasm progression, Spinal deformity, |
||||
DENOSUMAB, |
||||
| 1805 | 26590732 |
US |
1 | |
Night sweats, Fatigue, Bone pain, Muscular weakness, Joint stiffness, Thyroid function test abnormal, Gait disturbance, |
||||
ASFOTASE ALFA, |
||||
| 1806 | 26590770 |
EU |
71 | 2 |
Acute kidney injury, Asthenia, Dyskinesia, Limb discomfort, Movement disorder, Sleep talking, Device loosening, Decreased appetite, Fluid intake reduced, On and off phenomenon, Nausea, Dysgeusia, Device dislocation, Anxiety, Feeling hot, C-reactive protein increased, Urine output decreased, Rhabdomyolysis, Creatine kinase abnormal, Musculoskeletal stiffness, Somnolence, Tremor, Freezing phenomenon, Gait disturbance, Dysarthria, Anxiety, Malaise, Muscular weakness, Balance disorder, Bradykinesia, Fatigue, Freezing phenomenon, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, OPICAPONE, EZETIMIBE, RASAGILINE MESYLATE, FUROSEMIDE, |
||||
| 1807 | 26591433 |
US |
2 | |
Cerebrovascular accident, Anxiety, Pruritus, Post-traumatic stress disorder, Wheezing, Illness, Therapy interrupted, Depression, Colectomy, Gait disturbance, Sinus disorder, Hypersensitivity, |
||||
FAMOTIDINE, DIPHENHYDRAMINE HYDROCHLORIDE, GABAPENTIN, UMECLIDINIUM, CYCLOSPORINE, UBROGEPANT, LEVOTHYROXINE SODIUM, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, AMLODIPINE, BACLOFEN, CYCLOSPORINE, PENTOSAN POLYSULFATE SODIUM, GABAPENTIN, HYDROXYZINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1808 | 26591456 |
US |
62 | 2 |
Pain in extremity, Grip strength decreased, Gait disturbance, Decreased appetite, Weight decreased, Fatigue, Dry mouth, Feeding disorder, Insomnia, Anxiety, |
||||
MAVACAMTEN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 1809 | 26591727 |
US |
63 | 2 |
Rash erythematous, Gait disturbance, Skin burning sensation, Pruritus, Injection site pain, Skin discolouration, Hypersensitivity, Joint stiffness, Skin exfoliation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1810 | 26591907 |
US |
72 | 2 |
Gait disturbance, Hot flush, |
||||
SARILUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, |
||||
| 1811 | 26592068 |
CN |
79 | 1 |
Slow response to stimuli, Muscular weakness, Gait disturbance, |
||||
CARBAMAZEPINE, |
||||
| 1812 | 26592857 |
CA |
39 | |
Diplopia, Dizziness, Fatigue, Nausea, Retching, Gait disturbance, Abdominal pain upper, Myalgia, Headache, |
||||
OMALIZUMAB, |
||||
| 1813 | 26593007 |
CA |
86 | 2 |
Dementia, Gait disturbance, |
||||
ZOLEDRONIC ACID, |
||||
| 1814 | 26593107 |
US |
57 | 2 |
Pain, Malaise, Swollen joint count increased, Arthralgia, Gait disturbance, |
||||
SARILUMAB, |
||||
| 1815 | 26593116 |
TZ |
61 | 1 |
Gait disturbance, Drooling, Pleurothotonus, |
||||
DONEPEZIL HYDROCHLORIDE, RISPERIDONE, |
||||
| 1816 | 26593775 |
US |
1 | |
Hallucination, visual, Parkinson^s disease, Dementia with Lewy bodies, Condition aggravated, Mobility decreased, Gait disturbance, Delusion, Disorientation, General physical health deterioration, Product use issue, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, QUETIAPINE, |
||||
| 1817 | 26593969 |
US |
69 | 1 |
Tendon pain, Tendon disorder, Gait disturbance, |
||||
TIRZEPATIDE, |
||||
| 1818 | 26594437 |
US |
66 | 2 |
Depression, Gastrointestinal obstruction, Asthenia, Gait disturbance, Groin pain, Constipation, Muscle spasms, Discomfort, |
||||
| 1819 | 26595112 |
CA |
69 | 1 |
Hypoaesthesia, Intervertebral disc compression, Spinal cord injury, Fall, Posture abnormal, Back pain, Gait disturbance, Device power source issue, Device use error, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, IRBESARTAN, ENTACAPONE, PRAMIPEXOLE, EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE, EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, INSULIN GLARGINE, LIRAGLUTIDE, |
||||
| 1820 | 26595307 |
DO |
42 | 2 |
Limb operation, Limb operation, Gait disturbance, Haematoma, |
||||
GOLIMUMAB, |
||||
| 1821 | 26595371 |
EU |
54 | 2 |
Antinuclear antibody increased, General physical health deterioration, Dysstasia, Malaise, Gait disturbance, Hunger, Asthenia, Infection, Diarrhoea, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PSYLLIUM HUSK, CALCIUM, |
||||
| 1822 | 26595488 |
US |
81 | 2 |
Psoriatic arthropathy, Cellulitis, Immunodeficiency, Psoriasis, Osteoarthritis, Therapy interrupted, Microcytic anaemia, Drug ineffective, Paraesthesia, Depression, Obesity, Osteopenia, Lymphopenia, Blood immunoglobulin M increased, Light chain analysis increased, Insomnia, Alopecia, Nail disorder, Gait disturbance, |
||||
APREMILAST, HYDROCORTISONE, CYANOCOBALAMIN, IRON, |
||||
| 1823 | 26595876 |
EU |
63 | 2 |
Cerebrovascular accident, Infusion site bruising, Speech disorder, Hypoaesthesia, On and off phenomenon, Dyskinesia, Catheter site nodule, Catheter site haematoma, Infusion site erythema, Infusion site extravasation, Gait disturbance, Dysphagia, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, PRAMIPEXOLE, |
||||
| 1824 | 26595890 |
US |
1 | |
Hospitalisation, Haemoglobin abnormal, Autoimmune haemolytic anaemia, Haemoglobin abnormal, Gait disturbance, Feeling abnormal, Thinking abnormal, Visual impairment, Disorientation, Memory impairment, Occipital lobe stroke, Cerebrovascular accident, Platelet count abnormal, Obstruction, Confusional state, Mental disorder, Cerebral haemorrhage, |
||||
VENETOCLAX, VENETOCLAX, ALLOPURINOL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NIACIN, POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, |
||||
| 1825 | 26595919 |
GB |
74 | 1 |
Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, ACYCLOVIR, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1826 | 26595940 |
CN |
||
Pain, Gait disturbance, Off label use, |
||||
SELINEXOR, |
||||
| 1827 | 26596595 |
48 | 2 | |
Gait disturbance, Injection site warmth, Injection site pain, Injection site swelling, Injection site pruritus, Injection site erythema, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, FUROSEMIDE, DENOSUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, FAMOTIDINE, |
||||
| 1828 | 26599593 |
40 | 2 | |
Therapy interrupted, Malaise, Lethargy, Dizziness, Gait disturbance, Vomiting, Tremor, Migraine, Altered state of consciousness, |
||||
VILOXAZINE HYDROCHLORIDE, BUPROPION, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1829 | 26584196 |
US |
2 | |
Heart rate increased, Pain, Gait disturbance, Myalgia, Neuralgia, Asthenia, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, NALOXONE HYDROCHLORIDE NASAL, NALOXONE HYDROCHLORIDE, MACITENTAN, AZELASTINE HYDROCHLORIDE, AZELASTINE, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, TADALAFIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SOTATERCEPT-CSRK, SPIRONOLACTONE, MIDODRINE HYDROCHLORIDE, TORSEMIDE, ONDANSETRON HYDROCHLORIDE, ORPHENADRINE CITRATE, FERROUS SULFATE, |
||||
| 1830 | 26584577 |
43 | 2 | |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Adverse drug reaction, Adverse event, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Condition aggravated, Confusional state, Confusional state, Contusion, Deep vein thrombosis postoperative, Depression, Diarrhoea, Discomfort, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Ear pain, Epilepsy, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Frequent bowel movements, Gait disturbance, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injection site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Laboratory test abnormal, Laryngitis, Lip dry, Live birth, Liver disorder, Liver function test increased, Liver injury, Lower limb fracture, Lower respiratory tract infection, Lung disorder, Lupus-like syndrome, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Neck pain, Night sweats, Normal newborn, Obesity, Oedema peripheral, Onychomadesis, Onychomycosis, Osteoarthritis, Overlap syndrome, Pain, Pain in extremity, Pancreatitis, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Porphyria acute, Psoriatic arthropathy, Rash, Rectal haemorrhage, Red blood cell sedimentation rate increased, Respiratory disorder, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sinusitis, Sleep disorder, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Therapeutic product effect incomplete, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Ulcer haemorrhage, Urticaria, Vomiting, Weight increased, Wheezing, White blood cell count increased, Wound, Wound infection, X-ray abnormal, Maternal exposure during pregnancy, Underdose, Contraindicated product administered, Intentional product misuse, Incorrect route of product administration, Prescribed underdose, Product quality issue, Product use in unapproved indication, Product use issue, Intentional product use issue, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, |
||||
| 1831 | 26584633 |
GB |
86 | 2 |
Muscular weakness, Depressed mood, Arthralgia, Ageusia, Depression, Suicidal ideation, Tendon pain, Anxiety, Sleep disorder, Pain in extremity, Weight decreased, Decreased appetite, Bedridden, Gait disturbance, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CALCIUM, CANDESARTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, |
||||
| 1832 | 26584966 |
GB |
||
Myalgia, Arthralgia, Heart rate decreased, Muscular weakness, Depression, Oropharyngeal pain, Insomnia, Cough, Gait disturbance, Fatigue, Pruritus, Decreased appetite, |
||||
ROSUVASTATIN, |
||||
| 1833 | 26585078 |
JP |
11 | 1 |
Juvenile idiopathic arthritis, Arthralgia, Gait disturbance, Myalgia, Erythema nodosum, Arthritis, |
||||
DUPILUMAB, DUPILUMAB, MONTELUKAST SODIUM, MONTELUKAST SODIUM, |
||||
| 1834 | 26585175 |
US |
2 | |
Drooling, Gait disturbance, |
||||
DEUTETRABENAZINE, DEUTETRABENAZINE, |
||||
| 1835 | 26585327 |
ZA |
46 | 2 |
Hospitalisation, Injection site mass, Nausea, Pain in extremity, Gait disturbance, Decreased appetite, Heavy menstrual bleeding, Hypoglycaemia, Dizziness, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, |
||||
| 1836 | 26585555 |
US |
2 | |
Gait disturbance, Feeling abnormal, Tinnitus, Laryngospasm, Illness, Insomnia, Stress, |
||||
ROPEGINTERFERON ALFA-2B, |
||||
| 1837 | 26585736 |
US |
50 | 1 |
Loss of consciousness, Road traffic accident, Lower limb fracture, Impaired driving ability, Toxicity to various agents, Substance abuse, Drug screen positive, Glassy eyes, Limb injury, Dysarthria, Gait disturbance, Hiccups, Hypervigilance, Ocular hyperaemia, Logorrhoea, Lethargy, Slow speech, Feeling abnormal, Confusional state, Somnolence, Hyperhidrosis, Mydriasis, |
||||
HYDROMORPHONE HYDROCHLORIDE, DRONABINOL, HYDROCODONE BITARTRATE, ZOLPIDEM TARTRATE, ALPRAZOLAM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1838 | 26586050 |
US |
1 | |
Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1839 | 26586149 |
CA |
60 | 2 |
Blood pressure increased, Lip swelling, Paraesthesia oral, Ear pain, Weight increased, Muscular weakness, Breast pain, Gait disturbance, Blood urine present, Illness, Feeling abnormal, Pulse abnormal, Poor venous access, Fall, Loss of personal independence in daily activities, Blood pressure fluctuation, Inappropriate schedule of product administration, Toothache, Limb discomfort, Dysarthria, Nephrolithiasis, Brain fog, Pain in jaw, Nasopharyngitis, Transient ischaemic attack, Restlessness, Stress, Walking aid user, Arthralgia, Tooth infection, Head discomfort, Throat irritation, Feeling cold, Feeling drunk, Hypoaesthesia, Body temperature decreased, Heart rate decreased, Procedural pain, Humidity intolerance, Hypersomnia, Tooth fracture, Balance disorder, Blood pressure abnormal, Pain in extremity, Therapeutic product effect delayed, Dizziness postural, Pneumonia, Abscess oral, Swelling face, Neck pain, Facial pain, Swelling, Vaginal cyst, Tooth abscess, Weight decreased, Abdominal pain upper, Abdominal pain lower, Chest pain, Headache, Hypersensitivity, Vomiting, Paraesthesia, Malaise, Fatigue, Sinusitis, Back pain, Dizziness, Cough, Asthenia, Blood pressure decreased, Abdominal discomfort, Dyspnoea, Somnolence, |
||||
LISINOPRIL, LISINOPRIL, LISINOPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CANDESARTAN, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL BISULFATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, GABAPENTIN, MOMETASONE FUROATE, MOMETASONE, RABEPRAZOLE, RAMIPRIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ROSUVASTATIN, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUDESONIDE, MEPERIDINE HYDROCHLORIDE, HYALURONATE SODIUM, MAGNESIUM, MELATONIN, PRAMIPEXOLE DIHYDROCHLORIDE, PRAMIPEXOLE DIHYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, |
||||
| 1840 | 26586381 |
US |
1 | |
Hospitalisation, Drug hypersensitivity, Gait disturbance, Pyrexia, Rash, Incorrect dose administered, |
||||
DUPILUMAB, DUPILUMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1841 | 26586384 |
US |
54 | 2 |
Proteinuria, Glomerular filtration rate decreased, Viral infection, Rash, Weight increased, Food craving, Arthritis, Gait disturbance, Asthenia, Musculoskeletal stiffness, Pain, Vitamin D deficiency, Menopause, Blood potassium increased, Blood pressure increased, Product dose omission in error, |
||||
VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, VOCLOSPORIN, SPIRONOLACTONE, |
||||
| 1842 | 26586820 |
US |
1 | |
Inflammation, Vitreous floaters, Gait disturbance, |
||||
UPADACITINIB, |
||||
| 1843 | 26586903 |
|||
Gait disturbance, Drooling, Pleurothotonus, |
||||
DONEPEZIL HYDROCHLORIDE, RISPERIDONE, |
||||
| 1844 | 26586913 |
EU |
73 | 1 |
Polyneuropathy, Neuroborreliosis, Gait disturbance, |
||||
OBINUTUZUMAB, VENETOCLAX, VENETOCLAX, |
||||
| 1845 | 26587209 |
CA |
55 | 2 |
Abdominal distension, Gait disturbance, Insomnia, Malaise, Surgery, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, |
||||
| 1846 | 26587231 |
US |
72 | 2 |
Gait disturbance, Pain, Product quality issue, Product use in unapproved indication, |
||||
PENCICLOVIR, |
||||
| 1847 | 26587404 |
CA |
63 | |
Blister, COVID-19, Confusional state, Cystitis, Depressed mood, Dry skin, Fatigue, Feeling abnormal, Feeling of relaxation, Furuncle, Gait disturbance, Genital herpes, Headache, Hemiparesis, Infusion related reaction, Muscular weakness, Nasopharyngitis, Osteoporosis, Stress, Urinary tract infection, |
||||
OCRELIZUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DALFAMPRIDINE, RABEPRAZOLE SODIUM, RABEPRAZOLE, RABEPRAZOLE, RISEDRONATE SODIUM, CALCIUM, ERGOCALCIFEROL, MAGNESIUM, MIRABEGRON, |
||||
| 1848 | 26587489 |
US |
65 | 1 |
Gait disturbance, |
||||
RISANKIZUMAB-RZAA, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, PANTOPRAZOLE, GABAPENTIN, AMLODIPINE, QUETIAPINE, |
||||
| 1849 | 26587594 |
68 | 2 | |
Myalgia, Arthralgia, Gait disturbance, Therapy cessation, |
||||
ZOLEDRONIC ACID, ROSUVASTATIN, |
||||
| 1850 | 26588065 |
US |
51 | 2 |
Ear discomfort, Rib fracture, Fatigue, Diarrhoea, Gait disturbance, Hypoaesthesia, Sensory loss, Sinusitis, Nasal congestion, Migraine, Bone contusion, Fall, Sinus congestion, Paraesthesia, |
||||
CLADRIBINE, |
||||
| 1851 | 26588269 |
US |
87 | 2 |
Hospitalisation, Surgery, Musculoskeletal disorder, Pain in extremity, Psoriasis, Fall, Skin lesion, Accident, Lower limb fracture, Open fracture, Inappropriate schedule of product administration, Hip fracture, Upper limb fracture, Gait disturbance, Limb asymmetry, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, MUPIROCIN, MUPIROCIN CALCIUM, |
||||
| 1852 | 26588985 |
US |
1 | |
Renal failure, Renal injury, Gait disturbance, Dizziness, Therapy interrupted, |
||||
AVACOPAN, AVACOPAN, AVACOPAN, |
||||
| 1853 | 26589433 |
JP |
14 | 2 |
Neuropathy peripheral, Anxiety, Irritable bowel syndrome, Sleep disorder, Memory impairment, Menstrual disorder, Palpitations, Rash, Encephalitis, Encephalopathy, Perceptual disturbance, Cerebral circulatory failure, Gait disturbance, Hyperventilation, Cognitive disorder, Autonomic nervous system imbalance, Nervous system disorder, Immune system disorder, Encephalitis post immunisation, Hypothalamo-pituitary disorder, Mitochondrial cytopathy, Rheumatoid arthritis, Dementia, Gait inability, Seizure, Somnolence, Malaise, Headache, Muscular weakness, Arthralgia, Fatigue, Hypoaesthesia, Pelvic pain, Cold sweat, Feeling cold, Tremor, Depression, Orthostatic hypotension, Adverse event, Obsessive thoughts, Affect lability, Dysmenorrhoea, Nasal inflammation, Bronchitis chronic, Thyroid disorder, Collagen disorder, Dyslipidaemia, Tinnitus, Nightmare, Ataxia, Photophobia, Hyperacusis, Decreased appetite, Dyspnoea, Swollen tongue, Bone density decreased, Postural orthostatic tachycardia syndrome, Pollakiuria, Cerebrovascular disorder, Muscle twitching, Dyskinesia, Visual impairment, Cold sweat, Night sweats, Chest pain, Dry skin, Dysgeusia, Cough, Musculoskeletal chest pain, Bronchitis, Fibromyalgia, Dissociative disorder, Hypovitaminosis, Disturbance in attention, Back pain, Perceptual disturbance, Vaccination site bruising, Vomiting, Asthma, Arthralgia, Pain, Pain in extremity, Dizziness, Asthenia, Abdominal pain, Myalgia, Musculoskeletal stiffness, Myalgia, |
||||
| 1854 | 26589890 |
US |
73 | 2 |
Influenza like illness, Pain, Myalgia, Gait disturbance, Back pain, Pain of skin, |
||||
TIRZEPATIDE, |
||||
| 1855 | 26589945 |
US |
95 | 2 |
Cardiac failure congestive, Crying, Gait disturbance, Heart rate increased, |
||||
NERANDOMILAST, |
||||
| 1856 | 26590000 |
US |
75 | 2 |
Pain in extremity, Arthritis, Gait disturbance, Arthralgia, Joint swelling, |
||||
| 1857 | 26590076 |
US |
2 | |
Feeling abnormal, Gait disturbance, Malaise, Vomiting, Off label use, |
||||
TOPIRAMATE, OCRELIZUMAB, |
||||
| 1858 | 26593535 |
20 | 2 | |
Seizure, Sluggishness, Gait disturbance, Slow response to stimuli, |
||||
CENOBAMATE, |
||||
| 1859 | 26578368 |
US |
2 | |
Gallbladder operation, Gait disturbance, Fatigue, |
||||
ETANERCEPT, |
||||
| 1860 | 26578381 |
US |
2 | |
Drug delivery system issue, Gait disturbance, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 1861 | 26578435 |
US |
74 | 2 |
Pneumonia, Pulmonary oedema, Illness, Spinal fracture, Asthenia, Fatigue, Peripheral swelling, Wheezing, Weight increased, Extremity contracture, Feeling abnormal, Blood test abnormal, Productive cough, Musculoskeletal discomfort, Oxygen saturation decreased, Fracture, Arthralgia, Gait disturbance, Joint swelling, Pain in extremity, Injection site pain, Drug ineffective, Osteoporosis, Bone disorder, Sneezing, Abdominal discomfort, Amnesia, Nasopharyngitis, Cough, |
||||
INCLISIRAN, INCLISIRAN, INCLISIRAN, INCLISIRAN, INCLISIRAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, ERGOCALCIFEROL, |
||||
| 1862 | 26578486 |
US |
76 | 1 |
Pruritus, Blood pressure increased, Tremor, Gait disturbance, Mouth swelling, Illness, Drug hypersensitivity, Blood glucose decreased, |
||||
INSULIN GLARGINE, |
||||
| 1863 | 26578513 |
US |
81 | 1 |
Hallucination, Parkinson^s disease, Renal cancer stage III, Glaucoma, Hallucination, visual, Condition aggravated, Gait disturbance, Confusional state, Fall, Delusion, Ventricular extrasystoles, Cardiac murmur, Visual impairment, Hypoacusis, Walking aid user, Therapeutic product effect delayed, |
||||
PIMAVANSERIN TARTRATE, ATENOLOL, |
||||
| 1864 | 26578662 |
US |
77 | 1 |
Neuropathy peripheral, Hallucination, Initial insomnia, Nightmare, Frustration tolerance decreased, Dry mouth, Lip pruritus, Cheilitis, Throat irritation, Taste disorder, Thyroid disorder, Tremor, Walking aid user, Pruritus, Vomiting projectile, Oral mucosal exfoliation, Swelling face, Lip exfoliation, Insomnia, Nausea, Confusional state, Gait disturbance, Amnesia, Delusion, Cardiac disorder, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1865 | 26578747 |
US |
78 | 2 |
Urinary tract infection, Dysphagia, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1866 | 26579060 |
51 | ||
Psoriatic arthropathy, Rheumatoid arthritis, Psoriasis, Acne, Gait disturbance, Product dose omission issue, Product prescribing issue, Therapy interrupted, Product use in unapproved indication, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 1867 | 26579759 |
US |
74 | 1 |
Tremor, Gait disturbance, Muscular weakness, Abdominal distension, |
||||
TIRZEPATIDE, |
||||
| 1868 | 26579966 |
US |
77 | 1 |
Femur fracture, Fall, Gait disturbance, |
||||
RELUGOLIX, RELUGOLIX, ALLOPURINOL, AMLODIPINE BESYLATE, LISINOPRIL, PANTOPRAZOLE, SODIUM BICARBONATE, SODIUM BICARBONATE, INJECTION, SODIUM BICARBONATE INJECTION,, ENZALUTAMIDE, |
||||
| 1869 | 26580115 |
US |
2 | |
Lymphoedema, Respiratory disorder, Asthma, Headache, Pruritus, Rash, Renal disorder, Gait disturbance, Peripheral swelling, |
||||
DUPILUMAB, ALPRAZOLAM, AMLODIPINE, BUMETANIDE, LISINOPRIL, EVOLOCUMAB, ROSUVASTATIN, ZOLPIDEM TARTRATE, |
||||
| 1870 | 26580156 |
US |
2 | |
Feeling abnormal, Dyspnoea, Oxygen consumption increased, Chromaturia, Gait disturbance, |
||||
DUPILUMAB, CLONAZEPAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BUSPIRONE HYDROCHLORIDE, CLONIDINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, FAMOTIDINE, LOSARTAN, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PANTOPRAZOLE, |
||||
| 1871 | 26580365 |
US |
41 | 2 |
Diarrhoea, Vomiting, Ill-defined disorder, Flatulence, Weight decreased, Discomfort, Abdominal distension, Decreased appetite, Nocturnal dyspnoea, Food intolerance, Dairy intolerance, Condition aggravated, Dental plaque, Oedema peripheral, Kyphosis, Lip dry, Acanthosis nigricans, Muscle tone disorder, Gait disturbance, Abdominal rigidity, Salivary hypersecretion, Dysmenorrhoea, Bruxism, Asthenopia, Nail growth abnormal, Hair growth abnormal, Middle insomnia, Tooth disorder, Dry skin, Pallor, Short stature, Behaviour disorder, Coordination abnormal, Disturbance in attention, Increased appetite, Incorrect dose administered, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, TROFINETIDE, MAGNESIUM OXIDE, VITAMIN C, |
||||
| 1872 | 26580671 |
CO |
77 | 2 |
Gait disturbance, |
||||
DENOSUMAB, |
||||
| 1873 | 26581328 |
CA |
70 | 1 |
Diverticulitis, Drug effect less than expected, Gait disturbance, General physical health deterioration, Joint stiffness, Musculoskeletal pain, Musculoskeletal stiffness, Pneumonia, |
||||
RITUXIMAB, RITUXIMAB, |
||||
| 1874 | 26581784 |
AU |
60 | 1 |
Rheumatoid arthritis, Weight decreased, C-reactive protein increased, Gait disturbance, Pain, |
||||
INCLISIRAN, EZETIMIBE, METHOTREXATE, METHOTREXATE SODIUM, RIVAROXABAN, |
||||
| 1875 | 26581827 |
US |
55 | 2 |
Relapsing-remitting multiple sclerosis, Malaise, Gait disturbance, Dysstasia, Nystagmus, Tremor, Pain, Fatigue, |
||||
ALEMTUZUMAB, ALEMTUZUMAB, |
||||
| 1876 | 26581843 |
CA |
74 | 2 |
Dyspnoea, Hospitalisation, Gait disturbance, |
||||
DUPILUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, VALSARTAN, VALSARTAN ORAL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SERTRALINE, OXYGEN, 0XYGEN, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, |
||||
| 1877 | 26582184 |
2 | ||
Pain in extremity, Gait disturbance, Peripheral swelling, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 1878 | 26582753 |
CA |
84 | 1 |
Cognitive disorder, Small intestinal obstruction, Dysphagia, Gait disturbance, Hallucination, visual, Dysphonia, Parkinsonism, Respiratory disorder, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1879 | 26582756 |
CA |
74 | 2 |
Drug-induced liver injury, Gait disturbance, Joint range of motion decreased, Myalgia, Osteoarthritis, Pain in extremity, Musculoskeletal stiffness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1880 | 26583414 |
US |
54 | |
Dyspnoea, Condition aggravated, Physical deconditioning, Gait disturbance, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, VIGABATRIN, TREPROSTINIL, NINTEDANIB, NERANDOMILAST, |
||||
| 1881 | 26586426 |
67 | 2 | |
Infusion, Influenza like illness, Joint stiffness, Joint swelling, Gait disturbance, Pain, |
||||
ZOLEDRONIC ACID, ERGOCALCIFEROL, MAGNESIUM, CALCIUM, VITAMIN E, |
||||
| 1882 | 26577972 |
US |
51 | 2 |
Musculoskeletal disorder, Pain in extremity, Muscular weakness, Gait disturbance, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1883 | 26578008 |
US |
57 | 2 |
Loss of consciousness, Pneumonia, Tinnitus, Hypoacusis, Asthenia, Blood glucose increased, Ear discomfort, Gait disturbance, Alopecia, Vomiting, |
||||
TEPROTUMUMAB, INSULIN GLARGINE, |
||||
| 1884 | 26578158 |
EU |
72 | 1 |
Depressed level of consciousness, Device issue, On and off phenomenon, Abnormal dreams, Therapeutic product effect delayed, Therapeutic response shortened, Gait disturbance, Tremor, Reduced facial expression, Cognitive disorder, Muscle rigidity, Bradykinesia, Dyskinesia, Vasoconstriction, Stress, Catheter site erythema, Catheter site warmth, Catheter site extravasation, Middle insomnia, Catheter site related reaction, Mobility decreased, Pollakiuria, Disturbance in attention, Malabsorption from administration site, Parkinsonian gait, Catheter site mass, Catheter site infection, Hallucination, Catheter site induration, Muscle spasms, Thinking abnormal, Catheter site inflammation, Catheter site haematoma, On and off phenomenon, Loss of personal independence in daily activities, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1885 | 26577310 |
US |
1 | |
Abdominal abscess, Non-Hodgkin^s lymphoma, Bacterial infection, Gait disturbance, Asthenia, Illness, Product dose omission issue, |
||||
RAVULIZUMAB, |
||||
| 1886 | 26572637 |
US |
52 | 1 |
Cerebrovascular accident, Spinal fracture, Pallor, Mobility decreased, Therapy interrupted, Gait disturbance, Fall, Swelling face, Arterial occlusive disease, |
||||
ETANERCEPT, |
||||
| 1887 | 26572695 |
GB |
1 | |
Rheumatoid arthritis, Renal disorder, Chest discomfort, Urinary incontinence, Gait disturbance, Pain, Back pain, Neck pain, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 1888 | 26572752 |
EU |
79 | 1 |
Fall, Hallucination, Delusion, Gait disturbance, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1889 | 26572896 |
31 | ||
Pulmonary arterial hypertension, Dyspnoea, Gait disturbance, Anxiety, Tachycardia, Tachypnoea, Drug withdrawal syndrome, Maternal exposure during pregnancy, |
||||
HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METHYLPREDNISOLONE, PREDNISONE, |
||||
| 1890 | 26573021 |
US |
60 | 1 |
Pneumonia, Visual impairment, Gait disturbance, Adverse event, Memory impairment, |
||||
DEUTETRABENAZINE, VALBENAZINE, |
||||
| 1891 | 26573510 |
US |
71 | 2 |
Malignant melanoma, Infusion site erythema, Gait disturbance, Freezing phenomenon, Peripheral swelling, Limb discomfort, Inflammation, Joint swelling, Musculoskeletal discomfort, Arthritis, Lymphadenectomy, Device issue, Infusion site swelling, Infusion site pain, Infusion site mass, Infusion site bruising, |
||||
FOSCARBIDOPA/FOSLEVODOPA, PREDNISONE, AZATHIOPRINE, AMLODIPINE BESYLATE, CARBIDOPA AND LEVODOPA, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PRAMIPEXOLE DIHYDROCHLORIDE, RIVASTIGMINE TARTRATE, ROSUVASTATIN CALCIUM, CARBIDOPA AND LEVODOPA, AZATHIOPRINE, CLONAZEPAM, EZETIMIBE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 1892 | 26574217 |
EU |
78 | 2 |
Neuropathy peripheral, Small cell carcinoma, Muscle atrophy, Cardiac failure, Peripheral swelling, Joint swelling, Weight decreased, Weight increased, Gait disturbance, Muscle tightness, Muscle spasms, Blood alkaline phosphatase increased, Creatine kinase increased, Asthenia, Off label use, |
||||
PANTOPRAZOLE, DABRAFENIB, TRAMETINIB, TRAMETINIB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SELENIUM, |
||||
| 1893 | 26574349 |
GB |
||
Muscular weakness, Heart rate decreased, Myalgia, Depression, Arthralgia, Oropharyngeal pain, Gait disturbance, Fatigue, Decreased appetite, Cough, Insomnia, Pruritus, |
||||
ROSUVASTATIN, |
||||
| 1894 | 26574525 |
EU |
79 | 1 |
Hip fracture, Fall, Gait disturbance, Pelvic fracture, |
||||
RIVASTIGMINE, FINASTERIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, QUETIAPINE, |
||||
| 1895 | 26574542 |
US |
48 | 2 |
Arthralgia, Loss of personal independence in daily activities, Gait disturbance, Product dose omission in error, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1896 | 26574682 |
BR |
80 | 1 |
Neurotoxicity, Dyskinesia, Dysarthria, Confusional state, Gait disturbance, Overdose, Decreased appetite, Ataxia, |
||||
VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 1897 | 26574969 |
CA |
2 | |
Drug intolerance, COVID-19, Oral infection, Gingivitis, Neuromyelitis optica spectrum disorder, Bone disorder, Bone loss, Gait disturbance, Joint stiffness, Loose tooth, Muscle spasticity, Neuralgia, Tooth loss, |
||||
RITUXIMAB, SATRALIZUMAB, EMPAGLIFLOZIN, ERGOCALCIFEROL, |
||||
| 1898 | 26575006 |
72 | 2 | |
Bursitis, Deafness, Inflammatory marker increased, Disease progression, Joint swelling, Limb discomfort, Movement disorder, Gait disturbance, Inflammation, Musculoskeletal discomfort, Disease recurrence, Musculoskeletal stiffness, Pain in extremity, Polyarthritis, Drug intolerance, Nerve compression, Pain in jaw, Pain, Neck pain, Dry mouth, Electric shock sensation, Feeling abnormal, Glomerular filtration rate decreased, Hypersensitivity, Hypoaesthesia, Paraesthesia, Tachycardia, Headache, Tinnitus, Adverse event, Arthralgia, Back pain, Blood creatinine increased, |
||||
LOSARTAN POTASSIUM, LOSARTAN, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ROSUVASTATIN CALCIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 1899 | 26575210 |
US |
2 | |
Dyspnoea exertional, Dyspnoea, Gait disturbance, Muscular weakness, Fatigue, Adverse drug reaction, Unevaluable event, |
||||
BRENSOCATIB, BRENSOCATIB, OXYMETAZOLINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, BRIMONIDINE TARTRATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, AZELASTINE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BACLOFEN, CLOPIDOGREL BISULFATE, DUPILUMAB, LEFLUNOMIDE, LOSARTAN POTASSIUM, LOSARTAN, MEGESTROL ACETATE, NAPROXEN, NAPROXEN SODIUM, OXYGEN, 0XYGEN, PREDNISONE, DENOSUMAB, MONTELUKAST SODIUM, TIZANIDINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1900 | 26575341 |
CO |
52 | 2 |
Choking sensation, Cardiac failure, Pulmonary oedema, Skin ulcer, Gait disturbance, Blood glucose decreased, |
||||
ORAL SEMAGLUTIDE, EMPAGLIFLOZIN, INSULIN GLARGINE, INSULIN GLULISINE, SPIRONOLACTONE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
